ERS International Congress 2023: highlights from the Pulmonary Vascular Diseases Assembly

• Published in: ERJ open research Vol. 10; no. 1; pp. 847 - 2023
• Main Authors: Cullivan, Sarah, Boucly, Athénaïs, Jevnikar, Mitja, Lechartier, Benoit, Ulrich, Silvia, Bertoletti, Laurent, Sitbon, Olivier, Vonk-Noordegraaf, Anton, Bokan, Aleksandar, Park, Da-Hee, Genecand, Leon, Guiot, Julien, Jutant, Etienne-Marie, Piccari, Lucilla, Lichtblau, Mona
• Format: Journal Article Web Resource
• Language: English
• Published: England European Respiratory Society 01-01-2024
• Subjects: Cardiovascular & respiratory systems; Congress Highlights; Human health sciences; Life Sciences; Pulmonary and Respiratory Medicine; Sciences de la santé humaine; Systèmes cardiovasculaire & respiratoire; chronic thromboembolic pulmonary hypertension; new treatment; pulmonary arterial hypertension
• ISSN: 2312-0541; 2312-0541
• DOI: 10.1183/23120541.00847-2023

Pulmonary vascular diseases such as pulmonary embolism and pulmonary hypertension are important and frequently under-recognised conditions. This article provides an overview of key highlights in pulmonary vascular diseases from the European Respiratory Society International Congress 2023. This includes insights into disease modification in pulmonary arterial hypertension and novel therapies such as sotatercept and seralutinib. Exciting developments in our understanding of the mechanisms underpinning pulmonary hypertension associated with interstitial lung disease are also explored. A comprehensive overview of the complex relationship between acute pulmonary embolism and chronic thromboembolic pulmonary hypertension (CTEPH) is provided along with our current understanding of the molecular determinants of CTEPH. The importance of multidisciplinary and holistic care cannot be understated, and this article also addresses advances beyond medication, with a special focus on exercise training and rehabilitation.